Rebif Purple Book BLA 103780
- BLA number
- 103780
- Proprietary names
- Rebif
- Proper names
- interferon beta-1a
- Applicant
- EMD Serono, Inc.
- Center
- CDER
- First observed release
- 2020-05-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Rebif | interferon beta-1a | 351(a) | 22MCG/0.5ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2002-03-07 | |
| 002 | Rebif | interferon beta-1a | 351(a) | 44MCG/0.5ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2002-03-07 | |
| 003 | Rebif | interferon beta-1a | 351(a) | 8.8MCG/0.2ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2004-12-17 | |
| 004 | Rebif | interferon beta-1a | 351(a) | 8.8MCG/0.2ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2012-12-21 | |
| 005 | Rebif | interferon beta-1a | 351(a) | 22MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2012-12-21 | |
| 006 | Rebif | interferon beta-1a | 351(a) | 44MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2012-12-21 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2020-05-01 | R | 001 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
| 2020-05-01 | R | 002 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
| 2020-05-01 | R | 003 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
| 2020-05-01 | R | 004 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
| 2020-05-01 | R | 005 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
| 2020-05-01 | R | 006 | Rebif | 351(a) | Rx | EMD Serono, Inc. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2020-05-01 | 001 | Rebif | 351(a) | Rx | Licensed | 2002-03-07 |
| 2020-05-01 | 002 | Rebif | 351(a) | Rx | Licensed | 2002-03-07 |
| 2020-05-01 | 003 | Rebif | 351(a) | Rx | Licensed | 2004-12-17 |
| 2020-05-01 | 004 | Rebif | 351(a) | Rx | Licensed | 2012-12-21 |
| 2020-05-01 | 005 | Rebif | 351(a) | Rx | Licensed | 2012-12-21 |
| 2020-05-01 | 006 | Rebif | 351(a) | Rx | Licensed | 2012-12-21 |